Oncology

Following the presentation of practice-changing findings from RUBY and NRG-GY018 in patients with advanced or recurrent endometrial cancer at the SGO Annual Meeting in March 2023, data presented and published through the remainder of 2023 show that research in endometrial cancer continues at a pace.

Melanoma of the skin is a common type of cancer that primarily affects younger patients. In Stage III melanoma, which does not involve…

Renal cell carcinoma (RCC) is the most common primary tumour originating from the kidney, and accounts for more than 90% of all renal…

The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…

The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…

Endometrial cancer is the most common gynaecologic malignancy in high-income countries due to increased life expectancy. Approximately…

Although clinical trials form the backbone of evidence-based medicine, cohorts participating in clinical trials are often poorly…

Endometrial carcinoma (EC) is the world’s most common gynaecological malignancy, with a global incidence of 382,069 new cases and 89,929…